Korean Diet Efficacy Clinical Trial
A 13 Week Study to Examine the Effectiveness of the Korean Diet on Weight, Blood Pressure, Metabolic Parameters and Disease Control in an Australian Overweight and Obese Population.
1 other identifier
interventional
70
1 country
1
Brief Summary
To determine:
- 1.the acceptability of a Korean diet to an Australian overweight and obese population
- 2.which Korean recipes are easily prepared
- 3.the effect of a Korean diet on weight, blood pressure, and metabolic complications of obesity in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Jan 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 22, 2010
CompletedFirst Posted
Study publicly available on registry
May 14, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedMay 14, 2010
April 1, 2010
5 months
April 22, 2010
May 13, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
1. To investigate the acceptability of a Korean diet in overweight and obese Australians.
This will be determined at baseline and 4 week timepoints throughout the study by participants completing a Food Acceptability Questionnaire (FAQ). The FAQ addresses 10 components of food acceptability along a 7-point Likeart scale. The FAQ is a recognised instrument for testing food acceptability.
13 weeks
2. To examine the differences in weight loss between the Korean diet intervention and the Western diet intervention in overweight and obese Australians.
This will be determined by assessing differences at baseline and 12 weeks for weight, BMI and percent BMI change.
13 weeks
Secondary Outcomes (1)
To investigate changes in a number of indicators of metabolic disease in both groups - including anthropometry, Blood Glucose Levels, insulin sensitivity, lipid profiles, liver function, hormone function and inflammatory markers.
13 weeks
Study Arms (2)
Korean Diet
ACTIVE COMPARATORProvision of 2 Korean meals per day, 6 days per week
Western Diet
ACTIVE COMPARATORLifestyle counseling, dietary advice, grocery vouchers
Interventions
At each participant's baseline visit, participant's will have an individualised lifestyle session addressing dietary and exercise goals and techniques to achieve weight loss. Participants in the Korean diet group will pick up lunch and evening meals Monday-Friday. Raw ingredients and cooking instructions will also be provided on friday for saturday meal preparation. Ongoing lifestyle sessions will be performed weekly for participants.
At each participant's baseline visit, participant's will have an individualised lifestyle session addressing dietary and exercise goals and techniques to achieve weight loss. Participants in the Western diet group will be provided with a Western recipe cookbook and food vouchers (weekly) to purchase the necessary ingredients for the Western meal preparation. Ongoing lifestyle sessions will be performed weekly for participants.
Eligibility Criteria
You may qualify if:
- Residents of metropolitan Sydney
- Aged 18-65 years
- BMI 25-45kg/m2
You may not qualify if:
- Diabetes treated with oral medications or insulin
- Unstable angina or recent onset of cardiovascular disease
- Serious hepatic or renal disease
- serum transaminases (ALT or AST) \> 2.5 times upper limit of normal
- serum creatinine \> 1.5 times upper limit of normal or urinary microalbumin \>40 mg/L or eGFR \< 60ml/min/1.73m²
- Alcohol or illicit drug abuse
- Pregnant, breastfeeding, or planning pregnancy during the study
- Serious gastrointestinal disease (inflammatory bowel disease, active peptic ulcer, recent helicobacter pylori treatment)
- Treatment for an eating disorder, weight loss medications and other drugs that affect body weight e.g. some anti-psychotics, anti-depressants, or corticosteroids
- Hypothyroidism defined by elevated thyroid stimulating hormone (TSH) and low free thyroxine (fT4), or current hyperthyroidism under treatment
- Participation in another weight loss clinical trial within past 3 months
- Individuals who have lost \>10% weight within past 3 months
- Vegetarian eating practices
- Inability to cook or lack of facilities for home cooking
- Inability to read and write English
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sydneylead
- Inje Universitycollaborator
- Korea Agro-Fisheries Trade Corporation, Seoul, Koreacollaborator
- Ministry for Food, Agriculture, Forestry and Fisheries, Koreacollaborator
Study Sites (1)
The University of Sydney
Sydney, New South Wales, 2006, Australia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ian D Caterson, AM, MBBS, BSc(Med), PhD, FRACP
University of Sydney
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 22, 2010
First Posted
May 14, 2010
Study Start
January 1, 2010
Primary Completion
June 1, 2010
Study Completion
April 1, 2011
Last Updated
May 14, 2010
Record last verified: 2010-04